| Metrics | Details |
|---|---|
| Years | 2020-2035 |
| Base Year | 2025 |
| Market Size | 2450 |
| Regions | United States, Canada, Mexico |
| Segments | Type: Custom Oligonucleotides, Pre-designed Oligonucleotides, DNA Oligonucleotides, RNA Oligonucleotides, Modified Oligonucleotides, Others; Application: Diagnostics, Research, Therapeutics, Forensics, Others, Academic Applications; Technology: Solid-Phase Synthesis, Liquid-Phase Synthesis, Enzymatic Synthesis, PCR-based Synthesis, Microarray-based Synthesis, Others; Distribution Channels: Direct Tender, Online Sales, Distributors, Retail Sales, Contract/Third-Party Sales, Others; Organization Size: Small, Medium, Large |
| Players | Thermo Fisher Scientific, Agilent Technologies, Bio-Synthesis Inc., Kaneka Eurogentec, LGC Biosearch Technologies, Merck KGaA, Biogen Inc., Sarepta Therapeutics, GeneDesign Inc., Twist Bioscience, Genscript Biotech Corporation, Bioneer Corporation, Integrated DNA Technologies (IDT), BioSpring GmbH, Nitto Denko Avecia Inc. |
How Will You Befit From our consulting service
